Article Details

TiumBio doses first participant in Phase II trial of immuno-oncology drug

Retrieved on: 2024-10-07 20:50:17

Tags for this article:

Click the tags to see associated articles and topics

TiumBio doses first participant in Phase II trial of immuno-oncology drug. View article details on hiswai:

Excerpt

Data Insights. The gold standard of business intelligence. Find out more. This trial is designed to evaluate the safety ...

Article found on: www.clinicaltrialsarena.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo